Cardiac transplantation due to hemochromatosis. A pediatric case report

Carlos Alcántara1, María F Mendoza1, Dyan G Lúa1

  • 1Department of Cardiac Surgery; Hospital Infantil de México Federico Gómez, Mexico City, Mexico.

Insights

Hemochromatosis can cause severe heart failure in children. Heart transplantation successfully treated a pediatric patient, improving her quality of life and survival.

Area of Science:

  • Cardiology
  • Genetics
  • Transplantation

Background:

  • Hemochromatosis involves excess iron accumulation in organs.
  • Cardiac involvement in hemochromatosis significantly increases morbidity and mortality.
  • Pediatric end-stage heart failure presents unique management challenges.

Observation:

  • A pediatric patient presented with end-stage heart failure due to hemochromatosis.
  • The patient required and underwent a successful heart transplantation.
  • The procedure had no immediate complications.

Findings:

  • Post-transplantation, the patient demonstrated significant biochemical and clinical improvement.
  • The heart transplant positively impacted the patient's quality of life.
  • The patient experienced prolonged survival following the procedure.

Implications:

  • Heart transplantation is a viable and effective treatment for pediatric hemochromatosis-induced heart failure.
  • This case highlights the potential for improved long-term outcomes in young patients with severe cardiac iron overload.
  • Successful transplantation offers a pathway to enhanced survival and quality of life, challenging previous prognostic assumptions.